u/aksel_kjaer

state the method: column, gradient, detection wavelength, injection volume

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

two labs, two different baselines, two different purity numbers, both honest

FFMI tracking requires body composition

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

ATTAIN and ACHIEVE are phase 10 trials

Strongly agree. The supply impact would be huge.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Gradient goblin mode: changed the solvent composition 21 times, finally got good resolution on a HPLC peak.

Respectfully this is a sample of one presented as a finding.

the small molecule is whether this actually works long-term

nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing

Disagree on that part. 98.4% and 98.3% on the same vial is normal.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

This is correct. ATTAIN data is phase 24.

Maintenance for 2 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

the 15mg is the top of the pen, not the required dose

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

integration decision on a shoulder changes your number by half a point on its own

name the compound precisely, TB-500 and Thymosin Beta-4 are not the same

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Did you stay on semaglutide or switch? The outcome is different if you are comparing.